Pricing
The commercial path is deliberately narrow: qualify data access, sell a bounded paid audit, convert the work that repeats every week into a live tracker, then add sealed evidence exports once the workflow has proof.
Commercial sequence
Every price sits behind the proof step before it.
Demo
Show the synthetic proof loop.
Data-access qualification
Confirm export shape before paid work.
Paid retrospective audit
Measure historical follow-up risk.
Live subscription
Operate weekly follow-up handling.
Follow-Up Evidence Layer
Export evidence from live follow-up data.
First gate
Confirm lawful report-text export feasibility, minimum fields, privacy shape, and whether a paid audit can proceed.
Output
Export feasibility, minimum-field gaps, privacy posture, and a decision on whether a paid retrospective audit is credible.
Add-on
A$1,000–2,000
Optional written technical deliverable after qualification when the buyer needs documentation before audit approval.
Add-on
Add-on after live workflow proof
Board, insurer, quality, or medico-legal evidence exports from existing follow-up status data once the live workflow has value proof.
Price ladder
Pricing is volume-banded on annual CT+MRI report volume — the thing that drives the value delivered. Bands are indicative; tell us your volume and we confirm the band. Risk here means administrative documentation and follow-up evidence risk, not clinical risk scoring or patient outcome verification.
Retrospective audit · the wedge
01 / one-off audit · founding
A$5,000
First 5 clinics · up to 15,000 reports/yr · standard extract
A$2,500 creditable on conversion
First five eligible practices. Twelve months of CT+MRI reports within an agreed extract scope, turned into a governance-and-opportunity readout and an executive evidence pack.
Buying trigger
An early practice with accessible final-report exports that wants a bounded, paid proof readout before a live workflow.
02 / one-off audit
A$7,500
< 5,000 reports/yr
A$3,500 creditable on conversion
Retrospective audit for a single small site: recommendation volume, documentation gaps, administrative follow-up risk patterns, and a conversion plan.
Buying trigger
A small practice that needs defensible evidence of current follow-up handling before funding a tracker.
03 / one-off audit
A$12,500–15,000
5,000–15,000 reports/yr
A$5,000–7,500 creditable on conversion
Mid-volume retrospective audit: recommendation extraction, sampled human review, referrer distribution, and a sized in-network opportunity from the practice's own data.
Buying trigger
A growing group that wants the opportunity and governance readout quantified before a subscription.
04 / one-off audit
A$22,500–30,000
15,000–35,000 reports/yr
A$10,000–15,000 creditable on conversion
Higher-volume retrospective audit across the reporting load, with referrer-level distribution, sampled negatives, and a multi-site conversion plan.
Buying trigger
A larger group quantifying follow-up risk and opportunity ahead of a network rollout.
05 / one-off audit · scoped
Contact
35,000+ reports/yr or complex extract
Negotiated on conversion
Scoped retrospective audit for the largest groups or complex/legacy on-prem extracts. Extract effort is quoted separately (see extract note).
Buying trigger
A network or hospital group whose extract complexity or volume needs a bespoke audit scope.
Live subscription · annual
01 / annual subscription
A$24,000/yr
< 5,000 reports/yr
One small practice workflow: report-text intake, review queue, practice follow-up assignee, communication log, and evidence exports.
Buying trigger
Audit readout shows recurring follow-up work that needs weekly operating control.
02 / annual subscription
A$42,000/yr
5,000–15,000 reports/yr
Mid-market workflow with referrer views, exception register, and the in-network opportunity and governance screens.
Buying trigger
A growing group that needs a repeatable weekly follow-up operating loop with opportunity tracking.
03 / annual subscription
A$60,000/yr
15,000–25,000 reports/yr
Multi-site workflow with site views, review cadence, leadership reporting, and the governance evidence suite.
Buying trigger
A multi-site group that needs a repeatable follow-up operating room across teams.
04 / annual subscription
A$72,000–84,000/yr
25,000–35,000 reports/yr
Higher-volume multi-site workflow with the full referrer, opportunity, and governance reporting set.
Buying trigger
A larger group operating follow-up across many sites with leadership-level reporting needs.
05 / annual subscription · scoped
Custom
35,000+ reports/yr · multi-site
Network or hospital-group deployment: multi-site rollout, leadership and governance reporting, support model, and evidence exports — quoted to scope.
Buying trigger
Procurement requires a broader multi-site operating and support agreement after audit or tracker proof.
Bands are set on annual finalised CT+MRI diagnostic report volume for the scoped practice group, measured over the most recent completed 12 months, excluding duplicates and administrative addenda. Other modalities or additional entities are included by written scope amendment.
A portion of the audit fee is creditable against year-one subscription on conversion within 90 days. The credit is year-one only, non-refundable, non-transferable, excludes GST, and does not apply to extract fees.
Complex or legacy on-prem report extracts are scoped and quoted separately as an enterprise audit; third-party RIS/PACS vendor fees are not included.
All prices are in AUD and exclusive of GST. Enterprise audit and subscription are quoted to scope.
Commercial guardrails
No free pilots.
Annual agreements are the default for the live subscription.
Sales-led: scope and data access are qualified before payment; no online checkout.
Discounts buy logo, reference, or case-study rights only — never patient data or a data-for-discount swap.
All prices are in AUD, exclusive of GST, indicative, and subject to agreed scope and extract complexity.
No RIS, HL7, SFTP, FHIR, PACS, DIAS, MBS, TGA, or regulator-readiness claim is included in pricing.
Next step
If the practice cannot lawfully provide a usable final-report export, the right answer is to stop there. If it can, the audit scope becomes concrete enough to price and defend.